Trimurthi Live Share Price Today, Share Analysis and Chart

Name: Novelix Pharmaceuticals Ltd.: Is Infosys Ltd. worth buying?
Item: Novelix Pharmaceuticals Ltd.
Rating: 3.028083375
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Novelix Pharmaceuticals is into the business of Trading of Pharmaceuticals and related products and is into the business of trading of shares and securities.

61.99 0.16 (0.26%)

156.69% Gain from 52W Low

3,150

BSE Volume

BSE 31 Dec, 2025 11:44 AM (IST)

Loading... You have run out of DVM views!

Subscribe now to see details

High Financial Strength

- / 100

Mid Valuation

- / 100

Technically Moderately Bullish

66.1 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technicals but have medium valuation. At somewhat expensive valuations, investors should be cautious before buying View Similar Embed DVM

No estimates available

Trimurthi Live Price Chart

Loading Fundamental data..

Loading data..

Is Trimurthi Ltd. worth buying?

8 Votes:

Buy 87.5%

Sell 12.5%

Trimurthi Live Share Price Today, Share Analysis and Chart

Novelix Pharmaceuticals is into the business of Trading of Pharmaceuticals and related products and is into the business of trading of shares and securities.

156.69% Gain from 52W Low

SWOT Analysis

Trimurthi Live Price Chart